5AM Ventures VI, L.P. → Enliven Therapeutics, Inc. ELVN

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-03-31

DTC 2.86

6,053,456 shares short · -26.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $23.17M

Point72 Asset Mgmt

Other 13D/G Filings on Enliven Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2022-05-24	SC	New Enterprise Associates 14, L.P.	—	—	view →
2022-01-10	SC	New Enterprise Associates 14, L.P.	—	—	view →
2021-07-20	SC	Arix Bioscience plc	—	—	view →
2021-01-08	SC	Arix Bioscience plc	—	—	view →

Other Filings by 5AM Ventures VI, L.P.

Filed	Form	Issuer	Stake	Shares
2023-02-28	SC	CinCor Pharma, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →